Cargando…
716. In vitro and In vivo Nonclinical Efficacy of AR-501 (Gallium Citrate)
BACKGROUND: Gallium nitrate citrate exhibits strong antibacterial activity and was recently shown to be safe and efficacious when intravenously administered to cystic fibrosis patients in a Phase 2 clinical study conducted by the University of Washington. We are developing an inhaled formulation of...
Autores principales: | Woo, Jennifer, Hearne, Ken, Kelson, Andy, Yee, Luisa, Espadas, Cecilia, Truong, Vu L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811032/ http://dx.doi.org/10.1093/ofid/ofz360.784 |
Ejemplares similares
-
GALLIUM CITRATE, A NEW SENSITIZER OF CELLS TO HYPERTHERMIA
por: Shinohara, Kunio, et al.
Publicado: (1988) -
A Comparative Case Study between Gallium-67 Citrate Scintigraphy and Gallium-68 Citrate Positron Emission Tomography-Computed Tomography in Bone Infection
por: Johnson, Hanna Elizabeth, et al.
Publicado: (2022) -
Evaluation of Gallium Citrate Formulations against a Multidrug-Resistant Strain of Klebsiella pneumoniae in a Murine Wound Model of Infection
por: Thompson, Mitchell G., et al.
Publicado: (2015) -
674. Pre-Clinical and Phase I Safety Data for Anti-Pseudomonas aeruginosa Human Monoclonal Antibody AR-105
por: Loos, Andreas, et al.
Publicado: (2019) -
Fungal Planet description sheets: 716–784
por: Crous, P.W., et al.
Publicado: (2018)